 |
| Rodeina Challand |
In this episode, Rodeina Challand clears up some of the murkiness among the many terms associated with biosimilars. Then, we cover the legislation and guidelines affecting biosimilars, we discuss the possibilities of one global program, and finally talk about the future for a global standard.
For more information about PRA International, visit www.prainternational.com/.
Download Podcast Transcript (PDF)
See All PharmaVOICE podcasts
Download Companion Whitepaper -Global Biosimilar Development
